Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome

Purpose We aimed to report the clinical manifestations and immunological features of activated phosphatidylinositol 3-kinase δ syndrome 1 (APDS1) in a Chinese cohort. Moreover, we investigated the efficacy and safety of rapamycin therapy for Chinese patients with APDS1.